Chardan’s 2nd Annual Microbiome Medicines Summit

  • March 16, 2020 - March 16, 2020
  • New York, USA

Biomica is delighted to participate at Chardan’s 2nd  Annual Microbiome Medicines Summit. Dr. Haber will be available to participate in one-on-one meetings.

https://www.chardan.com/events/Xd6d5hQAACEAwiP-

Back to all News

Highlighted News About Biomica

May 23, 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting REHOVOT, Israel, May 23, 2024. Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: […]

Read More